Key Figures
Cicor Group Income Statement
|
in CHF 1 000 |
01.01. - 30.06.2025 |
in % |
01.01. - 30.06.2024 |
in % |
|
Order entry |
285 977 |
101.9 |
201 091 |
86.9 |
|
Net sales |
280 745 |
100.0 |
231 297 |
100.0 |
|
Change to previous year (in %) |
21.4 |
|
16.1 |
|
|
- Organic growth (in %) |
–2.1 |
|
–4.4 |
|
|
- Currency impact (in %) |
–1.4 |
|
–1.5 |
|
|
- Acquisitions (in %) |
24.8 |
|
22.1 |
|
|
EBITDA 1) |
26 458 |
9.4 |
24 729 |
10.7 |
|
Change to previous year (in %) |
7.0 |
|
15.9 |
|
|
Operating profit (EBIT) 1) |
15 404 |
5.5 |
15 116 |
6.5 |
|
Net profit |
8 478 |
3.0 |
11 886 |
5.1 |
|
Earnings per share (in CHF) |
1.94 |
|
2.69 |
|
|
Free Cash Flow before Acquisitions 1) |
9 379 |
|
21 079 |
|
|
CAPEX for tangible assets |
5 170 |
1.8 |
5 627 |
2.4 |
|
Number of employees (FTEs as per 30 June) |
4 238 |
|
3 301 |
|
1) Refer to note "2 Definition of Non-GAAP Measures".
Sales by Industry
Distribution of sales across markets is significantly influenced by the timing of acquisitions. On a pro-forma basis, including all transactions and assuming full 2025 sales from acquisitions, Cicor expects 36% of sales to the industrial sector, 28% to aerospace & defence and 19% to healthcare technology.
Sales by Region
Divisional Income Statement
|
in CHF 1 000 |
01.01. - 30.06.2025 |
in % |
01.01. - 30.06.2024 |
in % |
|
Net sales EMS Division |
263 114 |
100.0 |
208 524 |
100.0 |
|
EBITDA EMS Division |
24 300 |
9.2 |
24 109 |
11.6 |
|
|
|
|
|
|
|
Net sales AS Division |
19 257 |
100.0 |
23 868 |
100.0 |
|
EBITDA AS Division |
2 570 |
13.3 |
3 436 |
14.4 |
|
|
|
|
|
|
|
Net sales Corporate and eliminations |
–1 626 |
n/a |
–1 095 |
n/a |
|
EBITDA Corporate and eliminations |
–412 |
n/a |
–2 816 |
n/a |
|
|
|
|
|
|
|
Net sales Group |
280 745 |
100.0 |
231 297 |
100.0 |
|
EBITDA Group |
26 458 |
9.4 |
24 729 |
10.7 |
Cicor Group Balance Sheet
|
in CHF 1 000 |
30.06.2025 |
in % |
31.12.2024 |
in % |
|
Non-current assets |
132 889 |
26.7 |
114 166 |
27.4 |
|
Current assets |
363 983 |
73.3 |
302 899 |
72.6 |
|
Total assets |
496 872 |
100.0 |
417 065 |
100.0 |
|
Equity |
149 756 |
30.1 |
136 652 |
32.8 |
|
|
|
|
|
|
|
Financial liabilities |
122 068 |
24.6 |
118 301 |
28.4 |
|
Cash and cash equivalents |
–49 030 |
–9.9 |
–74 159 |
–17.8 |
|
Net debt |
73 038 |
14.7 |
44 142 |
10.6 |
|
Financial leverage (Net debt / EBITDA 1) ) |
1.16 |
|
0.74 |
|
|
|
|
|
|
|
|
Operating inventories 2) |
140 099 |
28.2 |
110 986 |
26.6 |
|
Operating trade receivables 2) |
93 143 |
18.7 |
70 783 |
17.0 |
|
Operating trade payables 2) |
–66 149 |
–13.3 |
–56 780 |
–13.6 |
|
Operating net working capital 2) |
167 093 |
33.6 |
124 989 |
30.0 |
|
in % of LTM net sales 1) |
25.2 |
|
24.8 |
|
1) Acquisitions are included for full twelve months pro-forma.
2) Refer to note "2 Definition of Non-GAAP Measures" for the definition of operating net working capital.